1Martelli M, Gherlinzoni F, De Renzo A, et al. Early autologous stem cell transplantation versus conventional chemotherapy as front-line therapy in high-risk,aggressive non-hodgkin's lymphoma: an Italian multicenter randomized trial.J Clin Oneol,2003,21:1255-1262. 被引量：1
2Magni M, Di Nicola M, Devizzi L, ctal. Successful in vivo purging of CD34- containing peripheral blood harvests in mantle and indent lymphoma:evidence for a role both chemotherapy and rituximab infusion.Blood ,2000,96:864-869. 被引量：1
3Johnson P, Glennie M. The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol,2003,30( suppl 2 ) :3-8. 被引量：1
4Press OW,Eary JF,Gooley T,et al. A phrase Ⅰ/Ⅱ trial of iodine-131-tositurnomab ( anti-CD20 ), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood,2000,96 : 2934-2942. 被引量：1
5Flohr T, Hess G, Kolbe K,et al. Rituxlmab in vivo purging is safety and effective in combination with CD34 positive selected autologous stem cell transplant for salvage therapy in B-NHL Bone Marrow Transplant,2002,29 : 769-775. 被引量：1
